Department of Anesthesiology, Weill Cornell Medical College, New York, New York, USA
Department of Anesthesiology, Weill Cornell Medical College, New York, New York, USA.
Reg Anesth Pain Med. 2020 Jun;45(6):468-473. doi: 10.1136/rapm-2019-100947. Epub 2020 Mar 18.
The current US opioid health-related crisis underscores the importance for perioperative physicians to optimize various approaches to pain management. Multimodal techniques and enhanced recovery after surgery (ERAS) protocols are frequently cited as the most effective strategies for improving the experience of pain and reducing opioid exposure. Complementary medicine (CM) techniques, while frequently shown to be effective at reducing opioid and other pharmacologic agent use, are rarely discussed as part of these multimodal strategies. In general, CM therapies are low-cost with minimal associated risk, making them an ideal choice for incorporation into ERAS and other opioid-sparing protocols. In this Daring Discourse, we discuss the benefits and challenges of incorporating CM therapy into anesthetic practice. We hope that anesthesiologists can become more familiar with the current evidence regarding perioperative CM therapy, and begin incorporating these therapies as part of their comprehensive multimodal approach to perioperative pain management.
当前美国阿片类药物相关健康危机凸显了围手术期医师优化各种疼痛管理方法的重要性。多模式技术和手术后强化康复（ERAS）方案经常被认为是改善疼痛体验和减少阿片类药物暴露的最有效策略。补充医学（CM）技术虽然经常被证明可以有效减少阿片类药物和其他药物的使用，但很少作为这些多模式策略的一部分进行讨论。一般来说，CM 疗法的成本低，相关风险极小，因此非常适合纳入 ERAS 和其他减少阿片类药物的方案。在本次大胆讨论中，我们讨论了将 CM 疗法纳入麻醉实践的益处和挑战。我们希望麻醉师能够更加熟悉围手术期 CM 疗法的现有证据，并开始将这些疗法纳入其围手术期疼痛管理的综合多模式方法中。
